Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.1000
-0.0700
(-2.21%)
At close: 4:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 710k | 710k | 2.3M | 14.09M |
| Low Estimate | 710k | 710k | 2.3M | 14.09M |
| High Estimate | 710k | 710k | 2.3M | 14.09M |
| Year Ago Sales | -- | -- | -- | 2.3M |
| Sales Growth (year/est) | -- | -- | -- | 513.19% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NTRBW | -- | -- | -- | -- |
| S&P 500 | 16.00% | 7.22% | 10.60% | 14.10% |
Related Tickers
OMGAQ
0.0309
-0.38%
RADX Radiopharm Theranostics Limited
5.0000
-5.84%
NBY NovaBay Pharmaceuticals, Inc.
0.6050
-0.84%
ELTX Elicio Therapeutics, Inc.
8.31
+0.48%
APRE Aprea Therapeutics, Inc.
2.5336
+0.14%
ADXN Addex Therapeutics Ltd
8.50
+0.59%
ACTU Actuate Therapeutics, Inc. Common stock
7.24
+4.47%
OXB.L Oxford Biomedica plc
330.00
+0.61%
KTTA Pasithea Therapeutics Corp.
1.1600
-4.92%
INKT MiNK Therapeutics, Inc.
8.95
-2.72%